Pharma IQ Members

Articles

Pharma IQ is devoted to keeping industry professionals abreast of the latest and most topical pharma news. Our pharmaceutical and biotechnology articles provide pharma professionals with comprehensive access up-to-date pharma news and information. Our pharma and biotech articles provide relevant, timely and actionable industry insight for pharma professionals. 

574 article results
of 57
July 26, 2016 by Pharma IQ
Pharma IQ
Much growth in the sector is being driven by expansion into developing markets, thus increasing demand for people with international experience. Taking the supply chain as an example, although track-and-trace initiatives should simplify and facilitate logistics in the long-term, in the short term there may be increasing competition for those with specialist knowledge of developing markets.
July 12, 2016 by Edward Simpson
lab
A single error that occurs in a pharmaceutical lab adversely impacts the health of thousands of patients. This is exactly why calibration in a pharmaceutical facility is highly regulated for precision and repeatability
June 14, 2016 by Pharma IQ
Pharma IQ
As Poland announces plans to create a British-style NHS, a recent paper has proposed that one priority should be to address the potential blurred boundaries between public bureaucracies, politicians and industry providers such as pharmaceutical companies.
Tags:
June 7, 2016 by Pharma IQ
Pharma IQ
Pharma and Cold Chain IQ explores the varying views and predictions on the potential outcomes which could occur from Brexit.
Tags:
May 17, 2016 by
Lab
Traditionally the pharma industry has lent toward the view of adhering to a one-size fits all approach to the application of therapeutics. However, now eyes are set firmly on the notion of personalised medicine – therapeutics tailored to a patient’s specific biomarker information. The progression of next generation sequencing and genome technology is allowing for the first tangible personalised therapies to emerge.
May 3, 2016 by Miss Chanice Henry
Pharma IQ Logo
Pharma IQ takes a look at some of the industry’s most prestigious movers and shakers causing ripples in the market over the last few months.
Tags:
April 28, 2016 by Chanice Henry
ici thumb
In order to examine the therapy which has been labelled as a game changing addition to oncology, earlier this month industry stakeholders met to explore the evidenced potential of immune checkpoint modulation therapies. The two day conference also saw attendees discuss and formulate tactics to scale the roadblocks encountered by the therapy.
Tags:
April 28, 2016 by Kate Torchilin Ph.D.
Pharma IQ Logo
Biomarkers are an essential part of such a translational effort and are critical to understanding human disease. Human biospecimens can provide a bridge between the early discovery and molecular mechanism of the disease and the clinical utility. Commonly, human biospecimens are used to:
Tags:
April 28, 2016 by Dr. Susan Shelby
Pharma IQ Logo
The balanced scorecard was first developed as a way for companies and organizations to more accurately measure their own performances. Today, these scorecards have evolved into vital tools for biopharmaceutical organizations to plan, measure, and manage their business strategies.
Tags:
574 article results
of 57